The ROE as of September 2024 (TTM) for Sage Therapeutics, Inc. (SAGE) is -60.43%

According to Sage Therapeutics, Inc.’s latest financial reports and current stock price. The company's current ROE is -60.43%. This represents a change of 299.35% compared to the average of -15.13% of the last 4 quarters.

Sage Therapeutics, Inc. (SAGE) Historical ROE (quarterly & annually)

How has SAGE ROE performed in the past?

The mean historical ROE of Sage Therapeutics, Inc. over the last ten years is -39.89%. The current -60.43% ROE has changed 51.50% with respect to the historical average. Over the past ten years (40 quarters), SAGE's ROE was at its highest in in the December 2020 quarter at 47.04%. The ROE was at its lowest in in the September 2017 quarter at -36.85%.

Sage Therapeutics, Inc. (SAGE) ROE by Quarter and Year

Discovering the peaks and valleys of Sage Therapeutics, Inc. ROE, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.

Sage Therapeutics, Inc. (SAGE) Average ROE

How has SAGE ROE performed in the past?

The current ROE of Sage Therapeutics, Inc. (SAGE) is greater than its 3-year, greater than its 5-year, and greater than its 10-year historical averages

Sage Therapeutics, Inc. (SAGE) ROE vs. Peers

How is SAGE’s ROE compared to its peers?

Sage Therapeutics, Inc.’s ROE is greater than Apellis Pharmaceuticals, Inc. (-139.02%), greater than Terns Pharmaceuticals, Inc. (-39.58%), greater than Day One Biopharmaceuticals, Inc. (-122.70%), greater than Blueprint Medicines Corporation (-85.25%), greater than Cerevel Therapeutics Holdings, Inc. (-98.94%), greater than Mirati Therapeutics, Inc. (-81.10%), greater than Amylyx Pharmaceuticals, Inc. (-46.15%), greater than Relay Therapeutics, Inc. (-43.66%), greater than Stoke Therapeutics, Inc. (-57.89%), greater than Pliant Therapeutics, Inc. (-41.05%), greater than Black Diamond Therapeutics, Inc. (-69.08%), greater than Arvinas, Inc. (-55.59%), less than Krystal Biotech, Inc. (13.36%), less than Alnylam Pharmaceuticals, Inc. (47.92%), greater than Madrigal Pharmaceuticals, Inc. (-95.61%), less than Incyte Corporation (2.10%), less than Reata Pharmaceuticals, Inc. (19.32%), greater than DiaMedica Therapeutics Inc. (-38.56%), greater than Akero Therapeutics, Inc. (-29.56%), greater than Nuvalent, Inc. (-28.83%), greater than Immunocore Holdings plc (-16.68%), greater than Ventyx Biosciences, Inc. (-61.43%),

Build a custom stock screener for Sage Therapeutics, Inc. (SAGE) and other stocks

One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Sage Therapeutics, Inc. using the financials and key metrics that matter to you in a single view.

The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:

Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.

Get your free trial here.

Sage Therapeutics, Inc. (SAGE) and other stocks custom spreadsheet templates

The easiest way to analyze a company like Sage Therapeutics, Inc. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.

Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.

Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.